Publications:

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology

Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W

Publication Date: 2022

Variant appearance in text: APC: 2045G>A; G682E

PubMed Link: 36238300

Variant Present in the following documents:

• Table_1.xlsx, sheet 4

View BVdb publication page

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine

Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W

Publication Date: 2022-09-19

Variant appearance in text: APC: 2045G>A; G682E

PubMed Link: 36123678

Variant Present in the following documents:

• 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.

European Journal Of Human Genetics : Ejhg

Elsayed, Fadwa A FA; Kets, C Marleen CM; Ruano, Dina D; van den Akker, Brendy B; Mensenkamp, Arjen R AR; Schrumpf, Melanie M; Nielsen, Maartje M; Wijnen, Juul T JT; Tops, Carli M CM; Ligtenberg, Marjolijn J MJ; Vasen, Hans F A HF; Hes, Frederik J FJ; Morreau, Hans H; van Wezel, Tom T

Publication Date: 2015-08

Variant appearance in text: APC: 2045G>A; Gly682Glu

PubMed Link: 25370038

Variant Present in the following documents:

• Main text

View BVdb publication page